Augmenting Real-World Data Through Modeling Key Clinical Trial Eligibility Criteria: An Example of Patients With Non-small-Cell Lung Cancer Treated With Pembrolizumab.
JCO Clin Cancer Inform
; 5: 849-858, 2021 08.
Article
in En
| MEDLINE
| ID: mdl-34415774
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Non-Small-Cell Lung
/
Lung Neoplasms
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
JCO Clin Cancer Inform
Year:
2021
Document type:
Article